New York S01817 mandates the Office of Addiction Services and Supports to promote clinical research on ibogaine for heroin, methamphetamine, and.
New York S01817 amends the mental hygiene law to require the Office of Addiction Services and Supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine, and cocaine addiction. The bill aims to explore the potential of ibogaine as a treatment option for these specific drug addictions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.